Cefuroxime: a Review of Its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

Overview

Journal Drugs

Specialty Pharmacology

Date 1979 Apr 1

PMID 37064

Citations 11

Authors

R N Brogden

R C Heel

T M Speight

G S Avery

Affiliations

Soon will be listed here.

Abstract

Cefuroxime is a new semisynthetic cephalosporin for parenteral administration. It is resistant to destruction by beta-lactamases produced by staphylococci and most Gram-negative aerobic bacteria and is active against many bacteria resistant to cephalothin. Cefuroxime is the most active of the cephalosporins against gonococci and Haemophilus influenzae particularly against beta-lactamase producing strains. Given by intramuscular or intravenous injection cefuroxime is effective against a wide variety of infections caused by Gram-positive or Gram-negative aerobes, but has no effect against infections caused by Pseudomonas aeruginosa or B. fragilis. Cefuroxime is of value in the treatment of respiratory infections due to Haemophilus influenzae and Streptocococcus pneumoniae and is useful against cephalosporin-resistant Klebsiella and Enterobacter infections. Cefuroxime is an alternative to spectinomycin for the treatment of beta-lactamase producing Neisseria gonorrhoeae infections. It is generally well tolerated and appears not to be nephrotoxic when given alone at usual dosages.

Citing Articles

The effect of antibiotic prophylaxis on the incidence of surgical site infection after laparoscopic appendectomy for chronic appendicitis.

Dai L, Jin X, Xie H, He T, Cheng H, Zhu Y Heliyon. 2023; 9(5):e15578.

PMID: 37153397 PMC: 10160511. DOI: 10.1016/j.heliyon.2023.e15578.

Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.

Rimmler C, Lanckohr C, Akamp C, Horn D, Fobker M, Wiebe K Br J Clin Pharmacol. 2019; 85(12):2864-2877.

PMID: 31487057 PMC: 6955413. DOI: 10.1111/bcp.14121.

Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players.

Lee Y, McMahan D, McCall C, Perry G Drugs. 2015; 75(18):2097-117.

PMID: 26612473 DOI: 10.1007/s40265-015-0506-7.

Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Singh J, Burr B, Stringham D, Arrieta A Paediatr Drugs. 2001; 3(10):733-61.

PMID: 11706924 DOI: 10.2165/00128072-200103100-00003.

Clinical use of cefuroxime in paediatric community-acquired pneumonia.

Olivier C Paediatr Drugs. 2000; 2(5):331-43.

PMID: 11022795 DOI: 10.2165/00128072-200002050-00001.

References

Brogden R, Heel R, Speight T, Avery G . Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1979; 17(1):1-37. DOI: 10.2165/00003495-197917010-00001. View

Bergogne-Berezin E, Even P, Berthelot G, Pierre J . Cefuroxime: pharmacokinetic study in bronchial secretions. Proc R Soc Med. 2010; 70(Suppl 9):34-7. PMC: 1543227. View

Gaya H, Brown E, Friedman P, Cox S . Comparative in vitro Activity of Cefuroxime and its Interactions with Aminoglycoside Antibiotics. Proc R Soc Med. 2010; 70(Suppl 9):51-5. PMC: 1543236. View

Moberg I, Wennberg K . Treatment of Females with Acute Gonorrhœa using Cefuroxime. Proc R Soc Med. 2010; 70(Suppl 9):128-30. PMC: 1543249. View

Capel-Edwards K, Atkinson R, Wheeldon J, Pratt D, Patterson G, Harman I . Effect of timing of cefuroxime dosage on its protection of rats against gentamicin nephrotoxicity. Infection. 1980; 8(1):41-2. DOI: 10.1007/BF01677398. View

Potaschmacher L, Dash C, Jefferson K, Kennedy M . A survey of the sensitivity of fresh clinical isolates to cefuroxime and other antibiotics. J Clin Pathol. 1979; 32(9):944-50. PMC: 1145856. DOI: 10.1136/jcp.32.9.944. View

Fowler W, Rahim G . Cefuroxime and post-gonococcal urethritis. Proc R Soc Med. 2010; 70(Suppl 9):131-3. PMC: 1543263. View

Renlund M, PETTAY O . Pharmacokinetics and clinical efficacy of cefuroxime in the newborn period. Proc R Soc Med. 2010; 70(Suppl 9):179-82. PMC: 1543252. View

Naumann P, Reintjens E . Antibacterial activity and pharmacokinetic behavior of cefazolin as compared with five other cephalosporin antibiotics. Infection. 1974; 2(1):19-24. DOI: 10.1007/BF01642219. View

10.

OCALLAGHAN C, Sykes R, Griffiths A, Thornton J . Cefuroxime, a new cephalosporin antibiotic: activity in vitro. Antimicrob Agents Chemother. 1976; 9(3):511-9. PMC: 429562. DOI: 10.1128/AAC.9.3.511. View

11.

Daikos G, Kosmidis J, Stathakis C, Giamarellou H . Cefuroxime: antimicrobial activity, human pharmacokinetics and therapeutic efficacy. J Antimicrob Chemother. 1977; 3(6):555-62. DOI: 10.1093/jac/3.6.555. View

12.

Sykes R, Griffiths A, Ryan D . Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae. Antimicrob Agents Chemother. 1977; 11(4):599-604. PMC: 352035. DOI: 10.1128/AAC.11.4.599. View

13.

Ritzerfeld W, Rangoonwala R . Susceptibility to cefuroxime 450 bacterial strains resistant to gentamicin. Proc R Soc Med. 2010; 70(Suppl 9):197. PMC: 1543231. View

14.

OCALLAGHAN C, Sykes R, Ryan D, Foord R, Muggleton P . Cefuroxime - a new cephalosporin antibiotic. J Antibiot (Tokyo). 1976; 29(1):29-37. DOI: 10.7164/antibiotics.29.29. View

15.

Neu H, Fu K . Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Antimicrob Agents Chemother. 1978; 13(4):657-64. PMC: 352306. DOI: 10.1128/AAC.13.4.657. View

16.

Eykyn S, Jenkins C, King A, Phillips I . Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole. Antimicrob Agents Chemother. 1976; 9(4):690-5. PMC: 429599. DOI: 10.1128/AAC.9.4.690. View

17.

Verbist L . Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. Antimicrob Agents Chemother. 1976; 10(4):657-63. PMC: 429810. DOI: 10.1128/AAC.10.4.657. View

18.

Moellering Jr R, SWARTZ M . Drug therapy: The newer cephalosporins. N Engl J Med. 1976; 294(1):24-8. DOI: 10.1056/NEJM197601012940106. View

19.

Jones R, Fuchs P, Gavan T, Gerlach E, Barry A, Thornsberry C . Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates. Antimicrob Agents Chemother. 1977; 12(1):47-50. PMC: 352152. DOI: 10.1128/AAC.12.1.47. View

20.

Gobernado M, Gudin J, Santos M, Gregori J, Canton E, Ferrando C . Cefuroxime in the treatment of bacterial infections in seriously ill patients admitted to an intensive care unit. Proc R Soc Med. 2010; 70(Suppl 9):86-9. PMC: 1543234. View